Nawah Scientific Raises $23M Series A Led by Life Ventures

Ten years after its launch, Egypt-based research and scientific services platform Nawah Scientific has secured $23 million in Series A funding as it moves to scale its cross-border laboratory network and research capabilities.

The round was led by Life Ventures Holding, with participation from Den Venture, Empire M, AfricInvest and Elsewedy, alongside angel investors and banking partners. The financing was structured as a blended round combining equity, debt and grant-based funding. Founded in 2015, Nawah provides research and scientific services spanning the medical, pharmaceutical and agricultural sectors, and currently operates facilities in Egypt, Saudi Arabia, the UAE and Poland.

The new capital will be used to support geographic expansion and deepen advanced research infrastructure. Nawah plans to establish a new global research centre in Rwanda and to double capacity at its laboratories in Egypt and Saudi Arabia. The company says it operates around 20,000 square metres of research facilities and has invested approximately $7 million in research and development over the past decade.

Nawah’s operations are organised across four main units. Its Life Sciences division works on areas including oncology, stem cells and nanotechnology applications. Pharma Services provides analytical and research support for drug development and manufacturing. The Food and Agriculture unit focuses on soil analysis and agricultural research, while Reference Materials supports quality assurance and regulatory compliance.

The Series A was signed during a ceremony marking Nawah’s tenth anniversary, held under the patronage of the Ministry of Higher Education and Scientific Research, and attended by government officials, financial institutions and research partners. The company has previously received financial and technical backing from Egypt Ventures and was selected among the YASR30 by the Yale Africa Startup Review.